Phaarmasia P/E Ratio
Current P/E Ratio
3.41
Low Valuation
Very Low - Potentially undervalued or facing challenges
Phaarmasia P/E ratio. Phaarmasia (PHRMASI) P/E ratio is 3.41 (Low), EPS (TTM) ₹25.74, current price ₹92.40 on BSE — Very Low - Potentially undervalued or facing challenges. Also explore Phaarmasia share price performance to track price trends across different timeframes.
Current Valuation Metrics
P/E Ratio
3.41
Current Price
₹92.40
EPS (TTM)
₹25.74
Exchange
BSE
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
56.46
Sector Median
32.5
Sector Rank
#3 of 199
Sector Percentile
1.5%
PHRMASI P/E Ratio — Valuation Signal & Historical Context
Phaarmasia P/E 3.41 — signal: Undervalued. For live price, revenue and the complete fundamental profile, see PHRMASI screener.
- Stock appears undervalued with PE of 3.41, suggesting potential buying opportunity
- Trading at discount to sector average PE of 56.46
PHRMASI vs Healthcare Peers — P/E Ratio Comparison
Phaarmasia P/E 3.41 vs Healthcare average 56.46, median 32.5 — range 2.04–740.29.
Sector Average
56.46
Sector Median
32.5
Lowest P/E
2.04
Highest P/E
740.29
Companies
199
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.04 | ₹65 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Sun Pharma Advanced Rese… | SPARC | 3.98 | ₹6,206 | Low |
| Dipna Pharmachem | DPL | 4.57 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.88 | ₹66 | Low |
| GKB Ophthalmics | GKB | 5.88 | ₹32 | Low |
| Kabra Drugs | KABRADG | 6.09 | ₹44 | Low |
| Royal Sense | ROYAL | 6.58 | ₹47 | Low |
| Colinz Laboratories | COLINZ | 6.62 | ₹18 | Low |
| Shelter Pharma | SHELTER | 6.96 | ₹59 | Low |